MRT Inc. (6034.T)
ValueMarkers Composite Index
55% below intrinsic value ($9)
MRT Inc. (6034.T) — VMCI valuation read
Headline read on 6034.T: VMCI of 56/100 versus a Healthcare sector median of 50. The 6-point above-median position is what makes MRT Inc. a relative-value candidate in the mid-cap cohort, before any pillar-level review.
Form 4 filings on 6034.T: zero in the trailing 30 days. The absence of insider transactions is itself a data point, just a low-information one. The thesis runs on financials and price action until that changes.
**Investor frame.** Three reads on 6034.T: value (6034.T trades at 27.0x earnings, 50% above the Healthcare median of 18.0x), quality (ROIC of 11.0% sits 1.0pp above the Healthcare median (10.0%)), and risk (net debt to EBITDA of -2.3x leaves covenant headroom). The value read also implies an EV/EBITDA gap of +4.0x against the Healthcare 12.0x baseline.
6034.T fell 2.1% over the trailing 7 days, with a -8.3% read on a 30-day basis.
MRT Inc. operates a medical information platform. The company provides temporary and part-time doctor services; doctor's career change support service; Door., an app to connect network of doctors; Door.into, which provides online health counseling, and online medical care; Pocket Doctor, a telemedicine/health consultation app; groupware for medical offices; FASTCALL that consolidates the functions required for hospital crisis management system as safety confirmation service for medical institution; and Good Doctors, which provides owned media sent by doctors. It also offers nurse and pharmacist recruitment service; human resources introduction service for clinical laboratory engineers, radiologists, and dialysis nurses, as well as for new business openings and succession projects; and recruitment information service for exclusive industrial physicians and contract industrial physicians. In addition, the company engages in employment agency business, opening of business, business succession support business, and PR business, and career support business. Further, it offers services for supporting the operation of medical institutions, such as fund management, utilizing medical fee factoring, payroll calculation for doctors' part-time jobs, and payroll transfer agency services. Additionally, the company sells human umbilical cord-derived stem cell culture supernatant; and provides babysitter services, tax accountant referral service, credit card payment agency service, questionnaire survey request for pharmaceuticals, etc., as well as media coverage cooperation, lecture request, event rescue, etc. It also publishes books on illness and treatment; and offers health maintenance service and member comprehensive compensation systems. The company was formerly known as Medical Research and Technology Co., Ltd and changed its name to MRT Inc. in September 2014. MRT Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.
Related Stocks in Healthcare
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.